Ménard S - Search Results

1

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Ménard S, Børresen-Dale AL. Bergamaschi A, et al. Among authors: menard s. J Pathol. 2008 Feb;214(3):357-67. doi: 10.1002/path.2278. J Pathol. 2008. PMID: 18044827

2

Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.

Triulzi T, Casalini P, Sandri M, Ratti M, Carcangiu ML, Colombo MP, Balsari A, Ménard S, Orlandi R, Tagliabue E. Triulzi T, et al. Among authors: menard s. PLoS One. 2013;8(2):e56761. doi: 10.1371/journal.pone.0056761. Epub 2013 Feb 18. PLoS One. 2013. PMID: 23441215 Free PMC article.

3

The 67 kDa laminin receptor as a prognostic factor in human cancer.

Ménard S, Tagliabue E, Colnaghi MI. Ménard S, et al. Breast Cancer Res Treat. 1998;52(1-3):137-45. doi: 10.1023/a:1006171403765. Breast Cancer Res Treat. 1998. PMID: 10066078 Review.

4

Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle.

Balsari A, Casalini P, Tagliabue E, Greco M, Pilotti S, Agresti R, Giovanazzi R, Alasio L, Rumio C, Cascinelli N, Colnaghi MI, Ménard S. Balsari A, et al. Among authors: menard s. Am J Pathol. 1999 Nov;155(5):1543-7. doi: 10.1016/S0002-9440(10)65470-3. Am J Pathol. 1999. PMID: 10550311 Free PMC article.

5

FOXP3 expression and overall survival in breast cancer.

Merlo A, Casalini P, Carcangiu ML, Malventano C, Triulzi T, Mènard S, Tagliabue E, Balsari A. Merlo A, et al. Among authors: menard s. J Clin Oncol. 2009 Apr 10;27(11):1746-52. doi: 10.1200/JCO.2008.17.9036. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255331

6

c-erbB-2 expression in primary breast cancer.

Tagliabue E, Ménard S, Robertson JF, Harris L. Tagliabue E, et al. Among authors: menard s. Int J Biol Markers. 1999 Jan-Mar;14(1):16-26. doi: 10.1177/172460089901400104. Int J Biol Markers. 1999. PMID: 10367245 Free article. Review.

7

Absence of microsatellite instability in breast carcinomas with both p53 and c-erbB-2 alterations.

Formantici C, Orlandi R, Ronchini C, Pilotti S, Ranzani GN, Colnaghi MI, Ménard S. Formantici C, et al. Among authors: menard s. J Pathol. 1999 Mar;187(4):424-7. doi: 10.1002/(SICI)1096-9896(199903)187:4<424::AID-PATH259>3.0.CO;2-0. J Pathol. 1999. PMID: 10398101

8

FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease.

Campiglio M, Pekarsky Y, Menard S, Tagliabue E, Pilotti S, Croce CM. Campiglio M, et al. Among authors: menard s. Cancer Res. 1999 Aug 15;59(16):3866-9. Cancer Res. 1999. PMID: 10463571

9

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.

Iorio MV, Casalini P, Tagliabue E, Ménard S, Croce CM. Iorio MV, et al. Among authors: menard s. Eur J Cancer. 2008 Dec;44(18):2753-9. doi: 10.1016/j.ejca.2008.09.037. Epub 2008 Nov 18. Eur J Cancer. 2008. PMID: 19022662 Review.

10

Role of HER2 gene overexpression in breast carcinoma.

Ménard S, Tagliabue E, Campiglio M, Pupa SM. Ménard S, et al. J Cell Physiol. 2000 Feb;182(2):150-62. doi: 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E. J Cell Physiol. 2000. PMID: 10623878 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

500 results

Search Page